Health
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – Yahoo Finance
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in…
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related to the potential development of a diagnostic for evaluating the presence or absence of a T-cell immune response…
-
Noosa News15 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General22 hours agoMinecraft mayhem: ‘Chicken jockey’ chaos reaches Australian cinemas
-
General16 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News18 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate